Skip to main content

Hodgkin’s Lymphoma

  • Chapter
Book cover Modern Hematology

Part of the book series: Contemporary Hematology ((CH))

  • 1900 Accesses

Abstract

Hodgkin’s lymphoma (HL) was first described by Thomas Hodgkin in 1832. Carl Sternberg and Dorothy Reed reported on the typical multinuclear giant cells and their relationship to the mononuclear Hodgkin cell. For more than a century, this disease was regarded as a chronic inflammatory disorder, which is reflected by the old term lymphogranulomatosis. However, because aneuploidy and monoclonality were detected in the cells, Hodgkin’s disease, or in terms of the World Health Organization (WHO) classification of malignant lymphomas, HL, today is considered a malignant tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  • Aisenberg AC. Problems in Hodgkin’s disease management. Blood 1999;93:761–779.

    PubMed  CAS  Google Scholar 

  • Aleman BM, Raemaekers JMM, Tirelli U, et al. Involved-field radiotherapy for advanced Hodgkin’s lymphoma. N Engl J Med 2003;348:2396–2406.

    Article  PubMed  Google Scholar 

  • Diehl V, Franklin J, Pfreundschuh M, et al. Standard and increased-doseBEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin’s disease. N Engl J Med 2003;348:2386–2395.

    Article  PubMed  CAS  Google Scholar 

  • Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. N Engl J Med 1998;339:1506–1514.

    Article  PubMed  CAS  Google Scholar 

  • Horning SJ, Hoppe RT, Breslin S, et al. Stanford V and radiotherapy for locally extensive and advanced Hodgkin’s disease: mature results of a prospective clinical trial. J Clin Oncol 2002;20:630–637.

    Article  PubMed  Google Scholar 

  • Meyer RM, Ambinder RF, Stroobants S. Hodgkin’s lymphoma: evolving concepts with implications for practice. Hematology (Am Soc Hematol Educ Program) 2004; 184–202.

    Google Scholar 

  • Munker R, Glass J, Griffeth LK, et al. Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin’s disease. Ann Oncol 2004;15:1699–1704.

    Article  PubMed  CAS  Google Scholar 

  • Urba WL, Longo DL. Hodgkin’s disease. N Engl J Med 1992;326:678–687.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Hiller, E., Munker, R. (2007). Hodgkin’s Lymphoma. In: Munker, R., Hiller, E., Glass, J., Paquette, R. (eds) Modern Hematology. Contemporary Hematology. Humana Press. https://doi.org/10.1007/978-1-59745-149-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-149-9_14

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-557-6

  • Online ISBN: 978-1-59745-149-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics